Group 1 - The stock of Hims & Hers Health, Inc. (HIMS) closed at $16.28, reflecting a decrease of -1.75% from the previous day's closing price, underperforming the S&P 500 which gained 0.13% [1] - Over the past month, HIMS stock has increased by 6.35%, outperforming the Medical sector's gain of 3.34% and the S&P 500's gain of 3.67% [1] Group 2 - Hims & Hers Health, Inc. is expected to report an EPS of $0.06, representing a 250% increase from the same quarter last year, with revenue forecasted at $378.82 million, indicating a 67.1% year-over-year increase [2] - For the full year, analysts project earnings of $0.22 per share and revenue of $1.39 billion, reflecting changes of +300% and +59.79% respectively from the previous year [3] Group 3 - Recent changes to analyst estimates for Hims & Hers Health, Inc. suggest a positive outlook for the company's business trends, with upward revisions indicating optimism [4] - The Zacks Rank system, which incorporates estimate changes, currently assigns Hims & Hers Health, Inc. a rank of 3 (Hold) [6] Group 4 - Hims & Hers Health, Inc. has a Forward P/E ratio of 77.01, which is a premium compared to the industry's average Forward P/E of 26.93 [7] - The Medical Info Systems industry, part of the Medical sector, holds a Zacks Industry Rank of 72, placing it in the top 29% of over 250 industries [7]
Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note